05.26.23 -- Key Considerations For Developing Next-Generation Antibody-Drug Conjugates
05/26/23 Pharmaceutical Online Newsletter
Stay updated with breaking news from Robert Bloder. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
05/26/23 Pharmaceutical Online Newsletter
Ascendia Pharmaceuticals Secures Growth Equity Investment from Signet Healthcare Partners News provided by Share this article Share this article NORTH BRUNSWICK, N.J., April 8, 2021 /PRNewswire/ -- Based in North Brunswick, NJ, Ascendia Pharmaceuticals, Inc. ("Ascendia") is a specialty contract development and manufacturing organization (CDMO) dedicated to developing and manufacturing enhanced formulations for pre-clinical, clinical stage drug candidates, and marketed drug products. The investment was made by Signet Healthcare Partners ("Signet"), a New York-based growth equity firm specializ...